| 000 | 01806 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250516072324.0 | ||
| 264 | 0 | _c20120112 | |
| 008 | 201201s 0 0 eng d | ||
| 022 | _a1533-4406 | ||
| 024 | 7 |
_a10.1056/NEJMoa1103151 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBelshe, Robert B | |
| 245 | 0 | 0 |
_aEfficacy results of a trial of a herpes simplex vaccine. _h[electronic resource] |
| 260 |
_bThe New England journal of medicine _cJan 2012 |
||
| 300 |
_a34-43 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGenitalia, Female _xvirology |
| 650 | 0 | 4 |
_aHerpes Genitalis _xprevention & control |
| 650 | 0 | 4 |
_aHerpes Simplex Virus Vaccines _xadverse effects |
| 650 | 0 | 4 | _aHerpesvirus 1, Human |
| 650 | 0 | 4 | _aHerpesvirus 2, Human |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aViral Envelope Proteins |
| 650 | 0 | 4 | _aVirus Shedding |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aLeone, Peter A | |
| 700 | 1 | _aBernstein, David I | |
| 700 | 1 | _aWald, Anna | |
| 700 | 1 | _aLevin, Myron J | |
| 700 | 1 | _aStapleton, Jack T | |
| 700 | 1 | _aGorfinkel, Iris | |
| 700 | 1 | _aMorrow, Rhoda L Ashley | |
| 700 | 1 | _aEwell, Marian G | |
| 700 | 1 | _aStokes-Riner, Abbie | |
| 700 | 1 | _aDubin, Gary | |
| 700 | 1 | _aHeineman, Thomas C | |
| 700 | 1 | _aSchulte, Joann M | |
| 700 | 1 | _aDeal, Carolyn D | |
| 773 | 0 |
_tThe New England journal of medicine _gvol. 366 _gno. 1 _gp. 34-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJMoa1103151 _zAvailable from publisher's website |
| 999 |
_c21435102 _d21435102 |
||